4.8 Article

Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase

Journal

NATURE COMMUNICATIONS
Volume 9, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-018-02938-1

Keywords

-

Funding

  1. National Institutes of Health [CA191263, NS089641, NS083629, CA157948]
  2. NIH SIG grant [1S10OD019972-01]
  3. NIH/NCI [R00CA1606638]
  4. American Cancer Society [ACS127951-RSG-15-025-01-CSM]
  5. Komen [CCR15332826]
  6. Ohio Cancer Research Associates
  7. DOD Breast Cancer Research Program [BC150596]
  8. Clinical and Translational Science Collaborative of Cleveland [UL1TR000439]
  9. Case Comprehensive Cancer Center [P30 CA043703]
  10. Cleveland Clinic VeloSano Bike Race
  11. Sontag Foundation
  12. American Cancer Society
  13. Blast GBM
  14. Case Comprehensive Cancer Center
  15. CDMRP [BC150596, 893164] Funding Source: Federal RePORTER

Ask authors/readers for more resources

Tumors adapt their phenotypes during growth and in response to therapies through dynamic changes in cellular processes. Connexin proteins enable such dynamic changes during development, and their dysregulation leads to disease states. The gap junction communication channels formed by connexins have been reported to exhibit tumor-suppressive functions, including in triple-negative breast cancer (TNBC). However, we find that connexin 26 (Cx26) is elevated in self-renewing cancer stem cells (CSCs) and is necessary and sufficient for their maintenance. Cx26 promotes CSC self-renewal by forming a signaling complex with the pluripotency transcription factor NANOG and focal adhesion kinase (FAK), resulting in NANOG stabilization and FAK activation. This FAK/NANOG-containing complex is not formed in mammary epithelial or luminal breast cancer cells. These findings challenge the paradigm that connexins are tumor suppressors in TNBC and reveal a unique function for Cx26 in regulating the core self-renewal signaling that controls CSC maintenance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available